Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MS
2017
Background:Pazopanib is an angiogenesis inhibitor approved for renal cell carcinoma and soft-tissue sarcoma. Studies indicate that treatment with pazopanib could be optimized by adapting the dose based on measured pazopanib plasma concentrations.Methods:We describe the validation and clinical applic
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
4
Citations
NaN
KQI